Regenerx Biopharmaceuticals Inc

SIC Pharmaceutical Preparations
Headquarters Rockville, MD
Financials
FORMNAMEDATE FILED
10-QQ15/15/202310-KFY 20224/11/2023NT 10-KNotification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT4054/3/202310-QQ311/14/202210-QQ28/12/202210-QQ15/16/202210-KFY 20213/30/2022
Prospectuses and Registrations
FORMNAMEDATE FILED
15-12GSecurities registration termination8/14/2023424B3Prospectus11/17/2021S-1/AGeneral form for registration of securities under the Securities Act of 19339/2/2021S-1General form for registration of securities under the Securities Act of 19338/16/2021424B3Prospectus8/17/2020424B3Prospectus8/17/2020424B3Prospectus3/30/2020
Proxies
FORMNAMEDATE FILED
DEF 14AOther definitive proxy statements7/11/2023PRE 14AOther preliminary proxy statements6/26/2023DEFR14ARevised definitive proxy soliciting materials10/19/2021DEF 14AOther definitive proxy statements10/18/2021PRE 14AOther preliminary proxy statements10/8/2021DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) material9/10/2019DEF 14AOther definitive proxy statements8/30/2019
News
FORMNAMEDATE FILED
8-KSubmission of Matters to a Vote of Security Holders8/7/20238-KEntry into a Material Definitive Agreement7/10/20238-KEntry into a Material Definitive Agreement6/21/20238-KAmendments to Articles of Incorporation or Bylaws; Change in Fiscal Year11/15/20218-KRegulation FD Disclosure7/22/20218-KEntry into a Material Definitive Agreement7/1/20218-KNews Release5/14/2021
Ownership
FORMNAMEDATE FILED
SC 13D/AEssetifin SPA7/6/20234Essetifin SPA7/6/20234Goldstein Allan L5/19/20224Bove Mauro5/19/20224Noseda Alessandro5/19/20224Elsey R Don5/19/20224Mcnay Joseph C5/19/2022
Others
FORMNAMEDATE FILED
EFFECTNotice of Effectiveness9/3/2021CORRESPCorrespondence9/3/2021UPLOADSEC-generated letter8/19/2021DNotice of Exempt Offering of Securities3/7/2019EFFECTNotice of Effectiveness10/23/2018CORRESPCorrespondence10/22/2018UPLOADSEC-generated letter10/18/2018